US vaccine fifth vaccine to win WHO emergency list
The World Health Organization said on Friday it had listed the Moderna COVID-19 vaccine for emergency use.
The enrollment process helps countries unable to assess the effectiveness of a vaccine on their own, providing them with access as quickly as possible and enabling the Covax vaccine exchange program and other partners to distribute it to the poorest countries.
The US vaccine is the fifth vaccine to win the WHO emergency list.
The United States Food and Drug Administration issued an emergency use authorization for the Moderna vaccine on December 18, 2020 and a marketing authorization valid throughout the European Union was issued by the European Agency for medication on January 6, 2021.
The WHO said in a statement that its Strategic Advisory Group of Experts on Immunization (SAGE) found the Moderna vaccine to be 94.1% effective.
Other vaccines listed for emergency use by WHO are Pfizer BioNTech; AstraZeneca; Indian Serum Institute; and Janssen.
Moderna announced Thursday that it plans to produce up to three billion doses of its vaccine in 2022 with new funding commitments to boost supply at manufacturing sites in Europe and the United States.